BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 4419386)

  • 21. Measurements of prolactin and androgens in patients with prostatic diseases.
    Saroff J; Kirdani RY; Chu TM; Wajsman Z; Murphy GP
    Oncology; 1980; 37(1):46-52. PubMed ID: 6153126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypogonadism in chronically lead-poisoned men.
    Braunstein GD; Dahlgren J; Loriaux DL
    Infertility; 1978; 1(1):33-51. PubMed ID: 12265605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of platelet aggregation caused by estrogen treatment in patients with carcinoma of the prostate.
    Eisen M; Napp HE; Vock R
    J Urol; 1975 Jul; 114(1):93-7. PubMed ID: 1142508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of various hormonal therapies for prostatic carcinoma.
    Geller J; Albert JD
    Semin Oncol; 1983 Dec; 10(4 Suppl 4):34-41. PubMed ID: 6199846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of diethylstilbestrol and medroxyprogesterone acetate on kinetics and production of testosterone and dihydrotestosterone in patients with prostatic carcinoma.
    Nolten WE; Sholiton LJ; Srivastava LS; Knowles HC; Werk EE
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1226-33. PubMed ID: 1002814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prolactin and cancer of the prostate (III). Changes in plasma prolactin and testosterone after hormone treatment in prostatic cancer].
    Maganto Pavón E; Mateos Torres JA; Mayayo Dehesa T; Allona Almagro A; Boronat Tormo F; Escudero Barrilero A
    Arch Esp Urol; 1982; 35(4):222-33. PubMed ID: 7138091
    [No Abstract]   [Full Text] [Related]  

  • 27. Influence of pituitary and adrenocortical hormones on prostatic secretion protein, a major protein in rat prostate.
    Pousette A; Björk P; Carlström K; Forsgren B; Högberg B; Gustafsson JA
    Prostate; 1982; 3(2):109-14. PubMed ID: 7088730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostatic cancer.
    Blacklock NJ
    Urol Res; 1977; 5(1):1-5. PubMed ID: 324081
    [No Abstract]   [Full Text] [Related]  

  • 29. Progressive enlargement of prostatic nodule after castration.
    Meares Em J
    JAMA; 1976 Dec; 236(23):2669. PubMed ID: 12277522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adrenocortical function in prostatic cancer patients: effects of orchidectomy or different modes of estrogen treatment on basal steroid levels and on the response to exogenous adrenocorticotropic hormone.
    Carlström K; Stege R
    Urol Int; 1990; 45(3):160-3. PubMed ID: 2161578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hormonal aspects of prostatic cancer: a review.
    Waxman J
    J R Soc Med; 1985 Feb; 78(2):129-35. PubMed ID: 2983074
    [No Abstract]   [Full Text] [Related]  

  • 32. Endocrine effects of combined treatment with an LHRH agonist in association with flutamide in metastatic prostatic carcinoma.
    Bélanger A; Labrie F; Dupont A; Brochu M; Cusan L
    Clin Invest Med; 1988 Oct; 11(5):321-6. PubMed ID: 2972431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bilateral adrenalectomy for advanced prostatic carcinoma.
    Schoonees R; Schalch DS; Reynoso G; Murphy GP
    J Urol; 1972 Jul; 108(1):123-5. PubMed ID: 5033992
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of ergobromocriptine on serum testosterone and prolactin levels in patients with carcinoma of the prostate.
    Taşar C; Akdaş A; Kirkali Z
    Int Urol Nephrol; 1986; 18(1):71-4. PubMed ID: 2424860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer of the breast. Endocrine and hormonal therapy.
    Kardinal CG; Donegan WL
    Major Probl Clin Surg; 1979; 5():361-404. PubMed ID: 379452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hormonal therapy of prostatic cancer.
    Scott WW; Menon M; Walsh PC
    Cancer; 1980 Apr; 45(7 Suppl):1929-36. PubMed ID: 7370944
    [No Abstract]   [Full Text] [Related]  

  • 37. Pituitary function after orchiectomy in patients with or without earlier estrogen treatment for prostatic carcinoma.
    Tomić R
    J Endocrinol Invest; 1987 Oct; 10(5):479-82. PubMed ID: 3123547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ["Carcinoma of the prostate". Endocrine treatment].
    RIVADENEYRA HINOJOSA J
    Rev Urol (Mex); 1963; 21():278-81. PubMed ID: 13974124
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hormone-therapy of carcinoma of the breast].
    Villani C; Mazzon I
    Minerva Ginecol; 1981 Jan; 33(1):3-26. PubMed ID: 7017505
    [No Abstract]   [Full Text] [Related]  

  • 40. HORMONAL CONTROL OF CANCER.
    STRONG JA
    Proc R Soc Med; 1963 Aug; 56(8):665-70. PubMed ID: 14052451
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.